SETUP

EW is breaking above $89.72 resistance with 2.41x average volume, closing near the high of the day bar at $90.09. The move clears a level that has acted as overhead supply, and price is now pushing toward the 52-week high of $96.29, leaving meaningful room to TP2 at $94.72. The breakout is clean on a closing basis, though entry here is slightly extended from the trigger level. Signal quality of 50/100 suggests this is not an early-stage breakout, so chase risk is real.

CATALYSTS

EW has beaten EPS estimates in five consecutive quarters, with the most recent April 2025 beat of 7.2% showing accelerating execution. The structural tailwind for transcatheter heart valves and structural heart procedures remains intact as an aging global population drives demand. Healthcare as a sector has shown defensive appeal during macro uncertainty. Next earnings are not until late 2026, removing near-term binary event risk.

RISKS

The P/E of 53.6x on $1.68 TTM EPS is elevated and leaves little margin for error if growth disappoints. Price sits about 6% below the 52-week high at $96.29, and that prior high represents a natural ceiling that could stall momentum before TP2. Insider activity shows primarily routine compensation-linked transactions, not conviction buying. Signal quality at 50/100 limits confidence in the entry timing. Stop at $88.32 is tight, roughly 2% below current price, meaning a minor pullback triggers the exit. No news catalyst is confirmed to sustain the move.

CONVICTION: Medium

Five straight earnings beats provide fundamental support, but a stretched valuation, elevated entry relative to the breakout level, and a below-average signal quality score keep this from being a high-confidence trade.